Financial insights of CMPOW

MyFinsight

For the quarter ending 2025-09-30.

Unit: Dollar

Income Statement	2025-09-30
Net sales	0
Cost of sales	0
Gross profit	0
Selling, general and administrative expenses	9,939,000
(loss) income from operations	-9,939,000
Revaluation of warrant liability	117,267,000
Revaluation of earnout consideration liability	-57,610,000
Change in fair value of derivative liability - convertible notes redemption make-whole provision	0
Interest expense	0
Interest income	287,000
Loss on extinguishment of debt	0
Amortization of deferred financing costs	0
Total other expense, net	-174,590,000
Loss before income taxes	-184,529,000
Income tax expense	29,804,000
Loss before earnings in equity method investment	-214,333,000
Earnings in equity method investment	39,637,000
Net loss	-174,696,000
Net loss attributable to redeemable non-controlling interests	0
Net loss attributable to composecure, inc	-174,696,000

Net loss per share attributable to composecure, inc. - basic (in usd per share)	-1.58
Net loss per share attributable to composecure, inc. - diluted (in usd per share)	-1.58
Weighted average shares used to compute net loss per share attributable to class a common stockholders - basic (in shares)	110,265,000
Weighted average shares used to compute net loss per share attributable to class a common stockholders - diluted (in shares)	110,265,000